跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
首页
药物
RNA-targeted therapeutic (cancer)
RNA-targeted therapeutic (cancer)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
TARGETED ANTI-PRDM COMPOSITIONS AND USES THEREOF
申请人: ARIZ PREC MEDICINE INC
优先权: 2023
US
WO
2 件公开
Multifunctional RNA nanoparticles and methods for treating cancer and therapeutic resistant cancer
申请人: UNIV CINCINNATI
优先权: 2017
US
Cd44 Variants As Therapeutic Targets
申请人: UNIV FLORIDA
优先权: 2005
US
Application of long-chain non-coding RNA LINC02620 as breast cancer biomarker and therapeutic target
申请人: TIANJIN CANCER HOSPITAL TIANJIN MEDICAL UNIV CANCER INSTITUTE & HOSPITAL
优先权: 2024
CN
Liver cancer targeting hepatitis B antisense RNA expression vector and its construction process and use
申请人: UNIV SHANDONG
优先权: 2002
CN
Mitochondrial specific transcription inhibitors
申请人: LUNELLA BIOTECH INC
优先权: 2023
CN
NOVEL SYSTEMS, VECTORS, AND METHODS FOR DELIVERY OF BIOMOLECULES TO EUKARYOTIC CELLS
申请人: TAO LIN
优先权: 2011
US
Application of STMN1 gene
申请人: SHANGHAI EAST HOSPITAL
优先权: 2017
CN
药物
反馈
RNA-targeted therapeutic (cancer)